Low-dose rituximab for the treatment of acute thrombotic thrombocytopenic purpura: Report of four cases-Reference-Cited by-同舟云学术

Low-dose rituximab for the treatment of acute thrombotic thrombocytopenic purpura: Report of four cases

Published:2013-07 Issue:4 Volume:18 Page:233-236
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Pequeño-Luévano Myrna¹,Villarreal-Martínez Laura¹,Jaime-Pérez José Carlos¹,Gómez-de-León Andrés¹,Cantú-Rodríguez Olga Graciela¹,González-Llano Oscar¹,Gómez-Almaguer David¹

Affiliation:

1. Department of Hematology‘Dr. José Eleuterio González’ University Hospital of the School of Medicine of Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1179/1607845412Y.0000000073

Reference18 articles.

1. Thrombotic Thrombocytopenic Purpura

2. von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome

3. TTP and ADAMTS13: When Is Testing Appropriate?

4. How I treat patients with thrombotic thrombocytopenic purpura: 2010

5. Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematologic Disorders and Stroke;Stroke;2022

2. Predictors of relapse and preventative strategies in immune thrombotic thrombocytopenic purpura;Expert Review of Hematology;2021-11-02

3. SUCCESSFUL TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA WITH PLASMAPHERESIS AND RITUXIMAB-A CASE SERIES;INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH;2021-09-01

4. The clinical efficacy of Rituximab administration in autoimmunity disorders, primary immunodeficiency diseases and malignancies;International Immunopharmacology;2021-06

5. Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remission;Transfusion and Apheresis Science;2020-12